Genetic variability of principal neutralizing determinants on HIV-1 gp41 and its correlation with subtypes
- 15 October 2005
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 101 (1) , 104-107
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Broadly Neutralizing Anti-HIV Antibody 4E10 Recognizes a Helical Conformation of a Highly Conserved Fusion-Associated Motif in gp41Immunity, 2005
- A novel monoclonal antibody specific to the C-terminal tail of the gp41 envelope transmembrane protein of human immunodeficiency virus type 1 that preferentially neutralizes virus after it has attached to the target cell and inhibits the production of infectious progenyVirology, 2003
- Neutralization Synergy of Human Immunodeficiency Virus Type 1 Primary Isolates by Cocktails of Broadly Neutralizing AntibodiesJournal of Virology, 2001
- Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41Journal of Virology, 2001
- N- and C-domains of HIV-1 gp41: mutation, structure and functionsImmunology Letters, 2001
- HIV Entry and Its InhibitionCell, 1998
- Core Structure of gp41 from the HIV Envelope GlycoproteinCell, 1997
- A Human Monoclonal Antibody to HIV-1 gp41 with Neutralizing Activity Against Diverse Laboratory IsolatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 1994
- Diagnosis of AIDS by Using a 12-Amino Acid Peptide Representing an Immunodominant Epitope of the Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1987